Crescita Therapeutics Strengthens Leadership Team with New Vice-President in Aesthetic and Cosmeceutical Business Unit

Tuesday, May 7, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

LAVAL, QC, May 7, 2019 /PRNewswire/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (Crescita or the Company), a Canadian commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions, diseases and their symptoms, is very pleased to announce that Mr. Jean

Colas has joined Crescita as Vice-President of its Aesthetic and Cosmeceutical business unit.

Jean's responsibilities will encompass sales team leadership, brand awareness, go-to-market strategy, marketing communications, and customer service.

"Jean is a great addition to the Crescita team and knows what it takes to deliver both brand and client success," said Serge Verreault, President and CEO of Crescita. "Jean's proven track record and business-first marketing approach will surely reinforce the value of the company's products and market position. I am certain that Jean will be instrumental in supporting Crescita's growth trajectory."

Jean brings over 30 years of sales, marketing and leadership experience to Crescita.  Prior to joining Crescita, Jean gained expertise growing and leading high-performance sales teams in North America, at Phytoderm, Cosinus Beauté International, and at L'Oréal, where he spent 10 years. Most recently, Jean was Senior Vice-President Sales and Marketing at DermoLab Pharma where he was mainly responsible for the complete rejuvenation of the Lotus Aroma brand, the development and expansion of new sales channels in Canada and the U.S. which contributed to the company's growth. Jean was also responsible for growing the Contract Manufacturing Organization business.

Jean holds a bachelor's degree in business administration from McGill University, and an MBA in Marketing and Finance from Queen's University. Jean is passionate about education and has been a lecturer since 2002 at both Concordia University and at the University of Sherbrooke, where he continues to lecture today.

"I am honored to join the group of highly-dedicated and driven individuals at Crescita, especially at such an exciting time of growth," said Jean Colas. "I am looking forward to sharing my vast experiences and creating actionable results." 

About Crescita Therapeutics Inc.Crescita (TSX: CTX and OTC US: CRRTF) is a publicly traded, Canadian commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions and diseases and their symptoms. Crescita owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active drugs into or through the skin. Please visit for additional information.


Cision View original content to download multimedia:

SOURCE Crescita Therapeutics Inc.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store